CIK 0001000228
- Large accelerated filer
HENRY SCHEIN INC
Sign in to watch- Ticker
- HSIC
- Exchange
- Nasdaq
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113136595
- Phone
- +1 631-843-5500
- Business address
- 135 DURYEA RD, MELVILLE, NY, 11747
- Former names
- SCHEIN HENRY INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-06 | Ettinger Michael S SVP Corp/Legal Ch of Staff Sec | Sale | −3,751 | $85.62 | $321K | 73,853 |
| 2022-05-04 | Connett Bradford C CEO, NA Distribution Group | Gift | −365 | 62,252 | ||
| 2022-05-04 | Ettinger Michael S SVP Corp/Legal Ch of Staff Sec | Gift | −215 | 94,965 | ||
| 2022-03-25 | Margulies Anne H. Director | Grant or award · Deferred Compensation Plan Phantom Stock | +306 | 6,106 | ||
| 2022-03-16 | Tuckson Reed Vaughn Director | Grant or award | +2,028 | 4,245 | ||
| 2022-03-16 | Siegel Walter Sr. VP & Chief Legal Counsel | Grant or award | +10,663 | 55,192 | ||
| 2022-03-16 | Siegel Walter Sr. VP & Chief Legal Counsel | Grant or award · Stock Option (Right to Buy) | +8,565 | 8,565 | ||
| 2022-03-16 | SHEARES BRADLEY T Director | Grant or award | +2,028 | 50,104 | ||
| 2022-03-16 | Serota Scott Philip Director | Grant or award | +2,028 | 2,028 | ||
| 2022-03-16 | Rekow E Dianne Director | Grant or award | +2,028 | 18,526 | ||
| 2022-03-16 | Raphael Carol Director | Grant or award | +2,028 | 27,483 | ||
| 2022-03-16 | PALADINO STEVEN EVP, Chief Financial Officer | Grant or award | +5,018 | 134,639 | ||
| 2022-03-16 | PALADINO STEVEN EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +4,031 | 4,031 | ||
| 2022-03-16 | MLOTEK MARK E EVP, Chief Strategic Officer | Grant or award | +17,155 | 83,040 | ||
| 2022-03-16 | MLOTEK MARK E EVP, Chief Strategic Officer | Grant or award · Stock Option (Right to Buy) | +13,780 | 13,780 | ||
| 2022-03-16 | McGlynn Lorelei SVP, Chief Human Res. Officer | Grant or award | +7,882 | 89,094 | ||
| 2022-03-16 | McGlynn Lorelei SVP, Chief Human Res. Officer | Grant or award · Stock Option (Right to Buy) | +6,331 | 6,331 | ||
| 2022-03-16 | Margulies Anne H. Director | Grant or award | +2,028 | 15,925 | ||
| 2022-03-16 | LASKAWY PHILIP A Director | Grant or award | +2,028 | 30,394 | ||
| 2022-03-16 | KUEHN KURT P Director | Grant or award | +2,028 | 15,780 |
Page 17 of 24 · 470 trades